Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Revue Neurologique
|
January 1, 1992
[Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]
B Brochet, J M Orgogozo, P Guinot, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 1, 1993
Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs
V Lagente, E Boichot, C Carre, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1989
Effect of Ginkgo biloba extract on microsomal enzyme induction
J C Duche, J Barre, P Guinot, et al.
Lancet (London, England)
|
January 31, 1987
Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man
K F Chung, G Dent, M McCusker, et al.
Water Research
|
December 21, 2010
A combined approach for a better understanding of wastewater treatment plants operation: statistical analysis of monitoring database and sludge physico-chemical characterization
A C Avella, T Görner, J Yvon, et al.
Annals of the Rheumatic Diseases
|
February 1, 1995
Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730
P Hilliquin, J Natour, J Aissa, et al.
Journal of the American Academy of Dermatology
|
August 1, 1990
Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063
A C Markey, J N Barker, C B Archer, et al.
Critical Care Medicine
|
January 6, 1999
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group
J F Dhainaut, A Tenaillon, M Hemmer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Revue Neurologique
|
January 1, 1992
[Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]
B Brochet, J M Orgogozo, P Guinot, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 1, 1993
Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs
V Lagente, E Boichot, C Carre, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1989
Effect of Ginkgo biloba extract on microsomal enzyme induction
J C Duche, J Barre, P Guinot, et al.
Lancet (London, England)
|
January 31, 1987
Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man
K F Chung, G Dent, M McCusker, et al.
Water Research
|
December 21, 2010
A combined approach for a better understanding of wastewater treatment plants operation: statistical analysis of monitoring database and sludge physico-chemical characterization
A C Avella, T Görner, J Yvon, et al.
Annals of the Rheumatic Diseases
|
February 1, 1995
Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730
P Hilliquin, J Natour, J Aissa, et al.
Journal of the American Academy of Dermatology
|
August 1, 1990
Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063
A C Markey, J N Barker, C B Archer, et al.
Critical Care Medicine
|
January 6, 1999
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group
J F Dhainaut, A Tenaillon, M Hemmer, et al.
Page
of 3